ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1518	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
535	"We are hoping it isn't another quick cash takeout, because of what we	Fitzhughlaw	4	6/1/2024
534	We are very excited about the IBRX prospects going forward, and are encouraging	bobbseytwins2001	7	6/1/2024
533	IMO, like most biotechs, low volume leads to lower prices. Seems these are the m	galt	2	6/1/2024
532	Not really responsive to the issue of upcoming catalysts, and not impatient, but	Fitzhughlaw	2	5/31/2024
531	Hey all - Quiet in here. … Catalysts coming up. ? Lung data? Few con	JJINV	-	5/31/2024
530	Except from NIH link states “ Most Medicare prescription drug plans covered the	Redman1234	-	5/27/2024
529	Glad that week is over... Hope all have a good long weekend....	JJINV	-	5/24/2024
528	Remember the IMMU "parking lot" checks? Anyone near any of the IBRX f	TripleE3	1	5/22/2024
527	I’m with ya fitz. Soon is no dummy - any placement would be locked up pretty	JJINV	-	5/20/2024
526	I agree that the stock price on any given day reflects the true value that the m	jargonweary	1	5/20/2024
525	After 50+ years of living the stock market almost nothing surprises us, especial	bobbseytwins2001	5	5/20/2024
524	Thanks Fitz, appreciate your thoughts. Concur on IMMU scars for all of us... O	Davidoff	2	5/20/2024
523	I'm not that concerned about dilution, per se, because a stock's PPS doe	Fitzhughlaw	3	5/20/2024
522	Beating the dead horse, I see today's price sub $7 as additional buying oppo	Davidoff	-	5/20/2024
521	Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick	End2War	-	5/17/2024
520	I have a personal interest in seeing the share price driven lower in the short t	Olecranon	1	5/17/2024
519	I agree100% with you. This will play out in our favor in the long run, but it ju	zagnut1	-	5/16/2024
518	To each is own but I prefer not to whine about the shorts. Do they manipulate t	jargonweary	8	5/16/2024
517	For those of you who don’t believe in shorts, today was a perfect example of man	zagnut1	-	5/16/2024
516	IBRX $7.79 $0.31 (3.83%) 16,503 Back oriondark3762 58m $IBRX NCCN on top of	End2War	4	5/16/2024
515	Most any informed research disprove the theory that shorting is "bad".	TripleE3	3	5/16/2024
514	To: TripleE3 who wrote ( 513) Loaning shares at 14% (annual) is not so brig	Huggenberg	1	5/15/2024
513	Did you have a "Fully Paid Lending Program" at TD Ameritrade? Was it	TripleE3	-	5/14/2024
512	Did you have to opt out? if so, did you need to call em?	JJINV	-	5/14/2024
511	for those who used ameritrade now Schwab.....I had cancelled my lending of IBRX	urslor	-	5/14/2024

Go to reply# or date (mm/dd/yy):